末期肾病血瘀证患者与动脉硬化的关系
The Association between Blood Stasis Syndrome and Arteriosclerosis in Patients with End Stage Renal Disease

作者: 朱元锵 , 李宗谚 , 王国辉 , 陈舜鼎 :长庚大学医学院传统中国医学研究所; 张恒鸿 :长庚大学医学院传统中国医学研究所;长庚纪念医院中医医院;

关键词: 血瘀证血液透析动脉重塑脉波传导速度Blood Stasis Syndrome Hemodialysis Arterial Remodeling Brachial Ankle Pulse Wave Velocity

摘要:

探讨末期肾病接受长期血液透析的病患族群其血瘀证表现与动脉重塑的关联性。方法:69位血液透析病患分为血瘀证组40例及非血瘀证组29比较、记录的项目包括心血管疾病病史及其危险因子并以脉波传导速度做为动脉硬化的指标、以足踝肱动脉血压比做为动脉粥状硬化的指标。结果:在长期血液透析的病患族群血瘀证与冠心病(p < 0.0001)及糖尿病(p = 0.018)有显着相关;血瘀证组平均年龄较高(p = 0.004);血瘀证组较非血瘀证组有较高的脉波传导速度(p < 0.0001)、收缩压(p = 0.019)及脉搏压(p = 0.004);而在其它心血管疾病危险因子两组无显着差异。进一步以logistic回归分析则发现脉波传导速度是血瘀证最重要的相关因子。结论:末期肾病血瘀证患者有较严重的动脉硬化的进展。

Abstract:
Object: To examine the association between the arterial remodeling and the presentation of blood stasis syndrome (BSS) in the end stage renal disease (ESRD) patients on hemodialysis. Methods: Sixty-nine ESRD patients on hemodialysis were separated into two groups, the BSS group (40 cases) and non-BSS group (29 cases). We recorded the history and risk factors of coronary artery disease, the brachial ankle pulse wave velocity (baPWV) as the marker of arteriosclerosis, and ankle brachial index (ABI) as the marker of atherosclerosis in ESRD patients on hemodialysis. Results: BSS group in hemodialysis patients is more associated with coronary artery disease (p < 0.0001) and diabetes mellitus (p = 0.018). Patients in BSS group possess higher baPWV (p < 0.0001), systolic blood pressure (p = 0.019) and pulse pressure (p = 0.004) as well as older age (p = 0.004) than patients in non-BSS group. There is no significant difference in the other cardiovascular risk factors between groups. Logistic regression revealed that baPWV was most associated with BSS among the above four significant factors. Conclusion: ESRD patients on hemodialysis with BSS exhibit more severe arteriosclerosis process than patients in non-blood stasis group.

文章引用: 朱元锵 , 李宗谚 , 王国辉 , 陈舜鼎 , 张恒鸿 (2013) 末期肾病血瘀证患者与动脉硬化的关系。 中医学, 2, 1-6. doi: 10.12677/TCM.2013.21001

参考文献

[1] 皮持衡, 谢胜. 慢性肾功能衰竭血瘀病机探析[J]. 北京中医, 1997, 5: 989.

[2] 王缨, 李国贤. 慢性肾衰竭患者血液流变学指标及血液黏滞综合征与血瘀证关系的研究[J]. 中国中西医结合肾病杂志, 2003, 4(2): 92-95.

[3] 屈凯, 王天芳, 赵燕等. 基于专家咨询问卷调查的慢性肾功能衰竭常见中医证候要素的研究[J]. 中西医结合学报, 2010, 8(12): 1147-1152.

[4] 陈维养. 陈可冀医学选集——七十初度[M]. 北京: 北京大学医学出版社, 2002: 304-348.

[5] R. N. Foley, P. S. Parfrey and M. J. Sarnak. Clinical epidemiology of cardiovascular disease in chronic renal failure. American Journal of Kidney Disease, 1998, 32(5): S112-S119.

[6] G. M. London, S. J. Marchais, A. P. Guerin, et al. Arterial structure and function in end-stage renal disease. Nephrology Dialysis Transplantation, 2002, 17: 1713-1724.

[7] A. P. Guerin, J. Blacher, B. Pannier, et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation, 2001, 103: 987-992.

[8] P. G. Greenland, J. Abrams, G. P. Aurigemma, et al. Prevention Conference V-Beyond secondary prevention: Identifying the high risk patients for primary prevention, noninvasive tests for atherosclerosis burden. Circulation, 2000, 101: 16-22.

[9] 中国中西医结合研究会第二次全国活血化瘀研究学术会议, 血瘀证诊断标准[J]. 中西医结合杂志, 1987, 7(3): 129.

[10] 高铸烨, 张京春, 徐皓等. 用复杂网络挖掘分析冠心病证候–治法–中药关系[J]. 中西医结合学报, 2010, 8(3): 238-243.

[11] 杨峰, 方淑媛. 应用活血化瘀法治疗糖尿病与血液流变学之关系的临床观察[J]. 中医函授通讯, 1994, 2: 38-39.

[12] I. H. De Boer, T. C. Rue, Y. N. Hall, et al. Temporal trend in the prevalence of diabetic kidney disease in the United States. Journal of the American Medical Association, 2011, 305(24): 2532- 2539

[13] R. A. Wolfe, V. B. Ashby, E. L. Milford, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. New England Journal of Medicine, 1999, 341: 1725-1730.

[14] 陈可冀, 张之南, 梁子钧等. 血瘀证与活血化瘀研究[M]. 台北: 知音出版社, 1999: 391-397.

[15] 赵燕. 脾肾两虚和瘀血痰浊与衰老机理的关系探要[J]. 中医药学, 2003, 21(5): 783.

[16] 谷万里, 史载祥, 余云旭等. 原发性高血压的中医证型特征[J]. 中西医结合学报, 2010, 8(9): 842-847.

[17] B. I. Levy, G. Ambrosio, A. R. Pries and H. A. J. Struijker- Boudier. Microcirculation in hypertension—A new target for treatment? Circulation, 2001, 104(6): 735-740.

[18] M. E. Safar, B. I. Levy and H. A. J. Struijker-Boudier. Current perspectives on arterial stiffness and pulse pressure in hyper-tension and cardiovascular disease. Circulation, 2003, 107(22): 2864- 2869.

[19] K. Scott, A. C. Mark, E. Mariko, et al. Endothe-lium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension, 2001, 38(5): 1049-1053.

[20] D. Karine, B. Jacques, P. G. Alain, et al. Endothelin and cardiovascular remodeling in end-stage renal disease. Nephrology Dialysis Transplantation, 1998, 13(2): 375-383.

分享
Top